nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR2—Peptide GPCRs—CXCR2—periodontitis	0.057	0.057	CbGpPWpGaD
Tasosartan—AGTR2—Peptide GPCRs—CCR2—periodontitis	0.0443	0.0443	CbGpPWpGaD
Tasosartan—AGTR2—ACE Inhibitor Pathway—TGFB1—periodontitis	0.0418	0.0418	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCL3—periodontitis	0.0416	0.0416	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCL3—periodontitis	0.0351	0.0351	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0279	0.0279	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCR2—periodontitis	0.0268	0.0268	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCR2—periodontitis	0.0226	0.0226	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL3—periodontitis	0.0213	0.0213	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.021	0.021	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCR2—periodontitis	0.0209	0.0209	CbGpPWpGaD
Tasosartan—AGTR1—Peptide GPCRs—CXCR2—periodontitis	0.0186	0.0186	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.018	0.018	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CCR2—periodontitis	0.0176	0.0176	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.0163	0.0163	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.0163	0.0163	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL13—periodontitis	0.0156	0.0156	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 signaling events—MET—periodontitis	0.0148	0.0148	CbGpPWpGaD
Tasosartan—AGTR1—Peptide GPCRs—CCR2—periodontitis	0.0144	0.0144	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL17A—periodontitis	0.0144	0.0144	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.014	0.014	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.0139	0.0139	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCR2—periodontitis	0.0137	0.0137	CbGpPWpGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—periodontitis	0.0136	0.0136	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL3—periodontitis	0.0136	0.0136	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL3—periodontitis	0.012	0.012	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL3—periodontitis	0.0109	0.0109	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCR2—periodontitis	0.0107	0.0107	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—ADRB1—periodontitis	0.0106	0.0106	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCL2—periodontitis	0.0103	0.0103	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL1A—periodontitis	0.00983	0.00983	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL10—periodontitis	0.00977	0.00977	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL4—periodontitis	0.0095	0.0095	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—periodontitis	0.00927	0.00927	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0091	0.0091	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FGF2—periodontitis	0.0088	0.0088	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCR2—periodontitis	0.00874	0.00874	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—VIP—periodontitis	0.00868	0.00868	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00812	0.00812	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—VIP—periodontitis	0.00789	0.00789	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCR2—periodontitis	0.00774	0.00774	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCR2—periodontitis	0.00703	0.00703	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL3—periodontitis	0.00693	0.00693	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00689	0.00689	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCL8—periodontitis	0.00685	0.00685	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00684	0.00684	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCR2—periodontitis	0.0068	0.0068	CbGpPWpGaD
Tasosartan—CYP3A4—Aflatoxin activation and detoxification—GGT1—periodontitis	0.00669	0.00669	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL3—periodontitis	0.00644	0.00644	CbGpPWpGaD
Tasosartan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.00621	0.00621	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCR2—periodontitis	0.00602	0.00602	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—ADRB1—periodontitis	0.00599	0.00599	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00586	0.00586	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IFNG—periodontitis	0.00575	0.00575	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCR2—periodontitis	0.00547	0.00547	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00545	0.00545	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—ADRB1—periodontitis	0.00544	0.00544	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—periodontitis	0.00536	0.00536	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CXCL8—periodontitis	0.00534	0.00534	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00532	0.00532	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.0053	0.0053	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCL2—periodontitis	0.00525	0.00525	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL1B—periodontitis	0.00512	0.00512	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00466	0.00466	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VIP—periodontitis	0.00466	0.00466	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00456	0.00456	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00454	0.00454	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCR2—periodontitis	0.00446	0.00446	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCR2—periodontitis	0.00415	0.00415	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL8—periodontitis	0.00415	0.00415	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MMP3—periodontitis	0.00414	0.00414	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TGFB1—periodontitis	0.00398	0.00398	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL3—periodontitis	0.00391	0.00391	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—periodontitis	0.00372	0.00372	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00356	0.00356	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL3—periodontitis	0.00355	0.00355	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCR2—periodontitis	0.00347	0.00347	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ADRB1—periodontitis	0.00346	0.00346	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00335	0.00335	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR2—periodontitis	0.00323	0.00323	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADRB1—periodontitis	0.00321	0.00321	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00301	0.00301	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—VIP—periodontitis	0.00283	0.00283	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL2—periodontitis	0.00269	0.00269	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00265	0.00265	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NTRK1—periodontitis	0.00263	0.00263	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—VIP—periodontitis	0.00257	0.00257	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCR2—periodontitis	0.00252	0.00252	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP3—periodontitis	0.00245	0.00245	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL8—periodontitis	0.00235	0.00235	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCR2—periodontitis	0.00229	0.00229	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00225	0.00225	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—periodontitis	0.00213	0.00213	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL3—periodontitis	0.0021	0.0021	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR2—periodontitis	0.00196	0.00196	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRB1—periodontitis	0.00195	0.00195	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR2—periodontitis	0.00178	0.00178	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00178	0.00178	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRB1—periodontitis	0.00177	0.00177	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL2—periodontitis	0.00171	0.00171	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL2—periodontitis	0.00159	0.00159	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VIP—periodontitis	0.00152	0.00152	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGF2—periodontitis	0.00144	0.00144	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR2—periodontitis	0.00135	0.00135	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—periodontitis	0.00135	0.00135	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MMP3—periodontitis	0.00135	0.00135	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00135	0.00135	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—periodontitis	0.00126	0.00126	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—periodontitis	0.0012	0.0012	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GGT1—periodontitis	0.00115	0.00115	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—periodontitis	0.00114	0.00114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR2—periodontitis	0.00105	0.00105	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB1—periodontitis	0.00105	0.00105	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—periodontitis	0.000938	0.000938	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—periodontitis	0.000878	0.000878	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTRK1—periodontitis	0.000858	0.000858	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP3—periodontitis	0.000797	0.000797	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—periodontitis	0.000764	0.000764	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—periodontitis	0.000707	0.000707	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—periodontitis	0.000694	0.000694	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000599	0.000599	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—periodontitis	0.000519	0.000519	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF2—periodontitis	0.000469	0.000469	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—periodontitis	0.00041	0.00041	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—periodontitis	0.00039	0.00039	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—periodontitis	0.000371	0.000371	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACP5—periodontitis	0.000353	0.000353	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—periodontitis	0.000306	0.000306	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—periodontitis	0.00023	0.00023	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GGT1—periodontitis	0.000196	0.000196	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARA—periodontitis	0.000141	0.000141	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—periodontitis	9.14e-05	9.14e-05	CbGpPWpGaD
